TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
INFU

InfuSystems Holdings Inc

Healthcare · Medical Devices

12.70$ +0.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement INFU
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – +438.1% +10.0% +21.2% +15.7% +7.7% +5.9% +6.8% +8.5% -2.3% +0.8% -5.5% +20.8% +20.1% +5.1% +7.4% +14.4% +7.2% +6.4%
– – – +467.3% +12.4% +32.5% +40.9% -17.5% +16.9% +2.9% +9.4% +23.0% +7.6% +1.5% +21.7% +12.8% +13.5% +12.6% +27.0% +2.8% -2.0%
– – – +428.5% +9.2% +17.1% +5.4% +21.4% +1.8% +8.4% +8.1% -12.6% -3.1% -10.0% +20.2% +25.3% -0.4% +3.5% +4.2% +11.6% +14.1%
– – – – – – – – – – – – – – – – – – – – –
– – -100.0% +140.5% +3.9% +68.8% -12.8% +28.2% -17.7% +5.3% +19.0% +3.6% +2.3% -1.4% +16.7% +21.4% +15.6% +8.5% +2.8% +12.9% +11.2%
– +84,955.5% -69.0% +231.9% +8.7% +47.9% -1.1% +19.9% -7.6% +0.6% +11.3% +3.4% +5.5% -16.4% +12.3% +15.2% +11.6% +5.7% +0.2% +7.6% +7.7%
– – – – +11.3% -117.6% – – +194.8% +58.3% -5.0% -89.0% -491.4% – +749.4% +150.4% -68.1% -41.3% +147.2% +68.6% +73.0%
– +334.7% +59,255.8% +387.2% -7.1% -4.3% -34.6% +52.3% +4.7% -10.4% -45.6% -21.2% -0.9% +6.6% +34.1% -34.1% +9.7% +1.8% +54.8% -18.1% -26.9%
– – – – -83.9% -284.1% – – – +130.0% -10.3% -106.5% – – – +394.9% -83.3% -89.7% +1,323.8% +173.3% +110.0%
– +4,087.9% +6.9% -18.3% +7.7% -240.3% – – – +176.7% -35.9% -107.8% – -99.7% +207.5% -6,105.5% – – +774.1% +177.2% +47.2%
– – – – -92.2% -339.3% – – – +101.1% +11.5% -105.9% – – – +1,173.5% -91.8% -98.7% +4,744.4% +168.9% +182.6%
– – – – -42.7% -33.8% -840.3% – +50.5% +8.8% +10.6% -31.5% -26.7% +35.9% +34.9% +44.7% -24.4% -13.7% +11.0% +21.2% +25.9%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?